AVBP Earnings

Quarterly EPS
$-0.61
Q3 2024
$-0.61
Q4 2024
$-1.90
Q1 2025
$-0.90
Q2 2025
$-0.83
Q3 2025
$-0.83
Q4 2025
$-0.96
Q1 2026
$-1.05
Q2 2026
Latest RevenueN/A
Latest Net Income-49893000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.050-49893000-16.7%
Q1 2026-$0.960-43320000+49.5%
Q4 2025-$0.830-35544000-36.1%
Q3 2025-$0.830-34978000-36.1%
Q2 2025-$0.900-31399000-38.5%
Q1 2025-$1.900-64387000-171.4%
Q4 2024-$0.610-20633000
Q3 2024-$0.610-20564000
Q2 2024-$0.650-21874000
Q1 2024-$0.700-17417000
ArriVent BioPharma (AVBP) — Earnings